Grand Rounds — Chemistry to Clinic: The Nanosyn Approach to Bridging the Gaps in Translational Research

Name: Grand Rounds — Chemistry to Clinic: The Nanosyn Approach to Bridging the Gaps in Translational Research
Uploaded: 2015-01-16T00:00:00+00:00
Description: Nikolai Sepetov, Ph.D., CEO, and chief scientific officer of Nanosyn Inc., presents Chemistry to Clinic: The Nanosyn Approach to Bridging the Gaps in Translational Research.

Nikolai Sepetov, Ph.D., CEO, and chief scientific officer of Nanosyn Inc., presents Chemistry to Clinic: The Nanosyn Approach to Bridging the Gaps in Translational Research.

Published

January 16, 2015

Created by

Related Videos

Saving lives with Gus: Ice fishing safety

Cornelius A. Thiels, D.O., M.B.A., and Martin D. Zielinski, M.D., Mayo Clinic physicians, share research findings on injuries experienced while ice fishing.

Center volume and hereditary hemorrhagic telangiectasia

Vivek N. Iyer, M.D., with Pulmonary and Critical Care Medicine at Mayo Clinic in Rochester, Minnesota, discusses a study of patients with the rare disease hereditary hemorrhagic telangiectasia.

Mayo Clinic researchers reduce inflammation in human cells, a major cause of frailty

Mayo Clinic researchers have discovered that targeting select pathways with JAK inhibitors reduced inflammation in human cells in culture dishes and decreased inflammation and frailty in aged mice.

Grand Rounds: Learning Healthcare Systems and the Veterans Affairs Clinical Assessment, Reporting and Tracking Program

Tom Maddox, M.D., presents Learning Healthcare Systems and the Veterans Affairs Clinical Assessment, Reporting and Tracking Program.

Mayo Clinic and collaborators find new class of drugs that reduces aging in mice

James L. Kirkland, M.D., Ph.D., discusses a study finding a new class of drugs, identified and validated by Mayo Clinic researchers and their collaborators, clearly reduces health problems in mice by limiting the effect of senescent cells.